RxDoctor Payments Data

Gregory Lagos, DO

Dermatology · South Charleston, WVNPI 1316946825

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 494 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 26.9% of the total.

$10,839in general payments, 2019–2025

Across 494 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Amgen$832
  • Sun Pharmaceutical Industries Inc.$821
  • Regeneron Healthcare Solutions, Inc.$607
  • E.r. Squibb & Sons, L.L.C.$548
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$10,43696%
  • Education$4034%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,839 in reported general payments places this provider in the 85th percentile of 39 dermatology providers in West Virginia.

See all dermatology providers in West Virginia

Medicare billing

Part B allowed, 2024
$150,884
Medicare patients
466
Services billed
2,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$75,113
Doxycycline Ir-DrDoxycycline Monohydrate12$5,529
Metronidazole56$3,840
Ketoconazole97$1,745
Clobetasol Propionate32$1,057
Fluorouracil18$1,051
Clindamycin Phosphate11$486
Triamcinolone Acetonide59$465
Doxycycline Hyclate20$170
Minoxidil25$100
Hydroxyzine Hcl13$34

Paid to pharmacies, not to this prescriber.

Other dermatology in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →